Vaughan Nelson Investment Management L.P. Grows Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Vaughan Nelson Investment Management L.P. raised its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 10.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 835,413 shares of the company's stock after buying an additional 76,950 shares during the period. Vaughan Nelson Investment Management L.P. owned about 0.97% of HealthEquity worth $73,826,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in HQY. Wealthfront Advisers LLC purchased a new position in HealthEquity in the fourth quarter worth $10,304,089,000. T. Rowe Price Investment Management Inc. purchased a new position in shares of HealthEquity in the 4th quarter worth about $78,107,000. Norges Bank purchased a new position in shares of HealthEquity in the 4th quarter worth about $74,701,000. Raymond James Financial Inc. bought a new position in shares of HealthEquity during the 4th quarter valued at about $45,728,000. Finally, Iron Triangle Partners LP purchased a new position in shares of HealthEquity during the 4th quarter valued at about $32,202,000. Institutional investors own 99.55% of the company's stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on HQY shares. Bank of America upped their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. KeyCorp reduced their target price on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Raymond James Financial raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. Finally, Royal Bank Of Canada raised their price objective on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday, June 4th. One research analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average price target of $118.09.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total value of $446,487.50. Following the completion of the transaction, the director now directly owns 84,969 shares of the company's stock, valued at $6,597,842.85. This represents a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the sale, the executive vice president now directly owns 75,689 shares in the company, valued at approximately $8,519,553.84. The trade was a 43.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 304,581 shares of company stock worth $33,664,018 over the last quarter. 1.50% of the stock is owned by corporate insiders.

HealthEquity Trading Up 2.1%

Shares of NASDAQ:HQY traded up $2.07 during midday trading on Wednesday, hitting $102.08. 390,800 shares of the stock traded hands, compared to its average volume of 842,909. The company has a quick ratio of 4.06, a current ratio of 4.06 and a debt-to-equity ratio of 0.50. The business's 50 day moving average is $94.79 and its two-hundred day moving average is $97.84. The stock has a market capitalization of $8.83 billion, a PE ratio of 74.16, a P/E/G ratio of 1.54 and a beta of 0.49. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The company had revenue of $330.80 million for the quarter, compared to the consensus estimate of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter in the previous year, the business earned $0.80 EPS. As a group, research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.